Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Hyperliquid Strategies Inc Common Stock (PURR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Hyperliquid Strategies Inc Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Hyperliquid Strategies Inc Common Stock trades at $11.11 (market cap $2.24B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 5.6× Hyperliquid Strategies Inc Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Hyperliquid Strategies Inc Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Hyperliquid Strategies Inc Common Stock for 1 Days on average.
| HALO | PURR | |
|---|---|---|
Market Cap | $12.58B | $2.24B |
Volume | 2,179,278 | 14,135,020 |
Sector | Health | Financials |
52-Week High | $115.22 | $14.09 |
52-Week Low | $61.63 | $3.10 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $2.10B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Hyperliquid Strategies Inc Common Stock
Hyperliquid Strategies is a digital asset treasury company focused on managing a treasury of HYPE tokens, the native digital assets of the Hyperliquid Layer-1 blockchain.
Read more on PURR →
